H3K27M mutations in the non-canonical H3.3 histone are mainly associated with mutations affecting the TP53 pathway, as these possibly offer evasion from cell death and senescence and provide the needed opportunity for the mutant H3.3K27M to exert its effect over a longer period, effectively reshaping the epigenome and drive tumour formation. Here, TP53 is linked to neoplasm.